protein

FTO

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about FTO: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

84Connections
0Hypotheses
2Analyses
50Outgoing
21Incoming
0Experiments
4Debates

Summary

Page for FTO Protein (Fat Mass and Obesity-Associated Protein)

View on Wiki →

No AI portrait yet

🔬 Protein Info
Gene SymbolFTO
AliasesFat Mass and Obesity-Associated Protein
FunctionFTO (Fat Mass and Obesity-Associated Protein), also known as ALKBH9, is a 505-amino acid nuclear and cytoplasmic protein that functions as an N6-methyladenosine (m6A) demethylase.
Subcellular Localization</strong> Nucleus, cytoplasm</div> <div class="infobox-row"><strong>Protein Fa
Molecular Weight58.6 kDa
Amino Acids505 aa
Pathwaysautophagy, adipogenesis, IGF1 signaling, Lipid Metabolism, Oxidative Stress
GeneCardsFTO
Human Protein AtlasFTO
Associated DiseasesAlzheimer's disease, Fat Mass And Obesity, Obesity
Known Drugs/CompoundsFB23, N6-Methyladenosine
InteractionsCERS6, DNA, IGF1, PARP1, RNA, UCP2
KG Connections84 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (1)

Knowledge base pages for this entity

FTO Protein (Fat Mass and Obesity-Associated Protein)

protein · 799 words

Pathway Diagram

graph TD
    FTO["FTO"]
    ATG5["ATG5"]
    FTO -->|"regulates"| ATG5
    ATG7["ATG7"]
    FTO -->|"regulates"| ATG7
    autophagy(["autophagy"])
    FTO -->|"activates"| autophagy
    adipogenesis(["adipogenesis"])
    FTO -->|"activates"| adipogenesis
    FTO -->|"regulates"| autophagy
    FTO -->|"regulates"| adipogenesis
    style FTO fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (63)

TargetRelationTypeStr
N6-Methyladenosinemodulatescompound0.95
m6A RNA methylationregulatesprocess0.95
Metabolic Disturbancesinhibitsphenotype0.95
Cognitive Declineinhibitsphenotype0.95
CDK2targetsprotein0.95

Incoming (21)

SourceRelationTypeStr
FB23inhibitsdrug0.95
Lactylationmodulatesprocess0.90
CDK2therapeutic_targetgene0.60
DNAregulatesgene0.60
DNAactivatesgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

What determines the specificity of RNA-protein interactions that drive distinct

neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.712

RNA binding protein dysregulation across ALS FTD and AD

neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.720

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (4)

Multi-agent debates referencing this entity

Debate: Liquid-to-Solid Transition Pathology Reveals Granule Weak Points

closed · Rounds: 4 · Score: 0.58 · 2026-04-27

While the study identifies G3BP1 as a central node triggering phase separation,

closed · Rounds: 4 · Score: 0.76 · 2026-04-21

RNA binding protein dysregulation across ALS FTD and AD

closed · Rounds: 4 · Score: 0.72 · 2026-04-12

RNA binding protein dysregulation across ALS FTD and AD

closed · Rounds: 4 · Score: 0.88 · 2026-04-06

Related Research

Hypotheses and analyses mentioning FTO in their description or question text

No additional research found